Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 Results After 1 Month: Research vs Marketing Comparison

Serum IGF-1 Elevation 'Massive GH boost' 18–25% mean increase from baseline (JCEM 2019) Significant but modest. Individual response varies 10–40% based on age and baseline Lean Body Mass Gain '5–10 lbs of muscle in 4 weeks' 0.8 kg mean increase, non-significan

This comparison does not assign a generated winner or score.

  • Serum IGF-1 Elevation
  • 'Massive GH boost'
  • 18–25% mean increase from baseline (JCEM 2019)
  • Significant but modest. Individual response varies 10–40% based on age and baseline
  • Lean Body Mass Gain
  • '5–10 lbs of muscle in 4 weeks'
  • 0.8 kg mean increase, non-significant vs placebo (JCEM 2008)
  • Not detectable at 30 days. Hypertrophy requires 8+ weeks sustained dosing
  • Fat Loss
  • 'Shreds body fat rapidly'
  • No significant reduction in fat mass at 4 weeks (multiple trials)
  • GH does stimulate lipolysis, but measurable fat loss requires 12+ weeks and caloric deficit
  • Sleep Quality
  • 'Improves rest and recovery'
  • 50% increase in REM duration, 20% increase in slow-wave sleep (Psychoneuroendocrinology)
  • Objective and significant. One of the most consistent first-month effects
  • Strength Increases
  • 'Rapid strength gains'
  • No performance benefit detected in 4-week trials
  • Strength adaptations lag behind IGF-1 elevation. Neural and hypertrophic gains appear after 8–12 weeks
  • Water Retention
  • Rarely mentioned
  • 2–4 lbs intracellular fluid gain in most users
  • Common and benign. Mistaken for muscle gain or fat gain depending on user expectation
More references

Related material